Recent Company News

• 04:15 AM ET Sep 04, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 12:50 PM ET Sep 26, 2025
  

  White House says the latest pharmaceutical tariffs do not apply to countries with negotiated trade deals -- wires

• 08:42 AM ET Sep 26, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 08:15 PM ET Sep 25, 2025
  

  Trump says pharmaceutical products imported into US will be hit with 100% tariff starting 1-Oct - Truth Social post

• 02:54 AM ET Sep 22, 2025
  

  StreetAccount Summary - European pre-market trading update

• 01:05 AM ET Sep 22, 2025
  

  Ipsen initiates Phase III of LANTIC trial of IPN10200 (€115.00, 0.00)

• 08:01 AM ET Sep 19, 2025
  

  Ipsen's Bylvay (odevixibat) approved in Japan for rare liver disease PFIC (€114.50, +0.30)

• 01:05 AM ET Sep 04, 2025
  

  IRLAB Therapeutics granted a patent strengthening the market exclusivity of the drug candidate mesdopetam in China (SEK 2.76, 0.00)

• 10:12 PM ET Aug 20, 2025
  

  RBC Capital Markets transfers ALM.SM, BIOA.B.SS, FYB.GR, others